These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2999403)
1. New antiallergic pyrano [3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma. Cairns H; Cox D; Gould KJ; Ingall AH; Suschitzky JL J Med Chem; 1985 Dec; 28(12):1832-42. PubMed ID: 2999403 [TBL] [Abstract][Full Text] [Related]
2. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acid. 2. Some benzothienoquinolinecarboxylic acids. Wade JJ; Erickson EH; Hegel RF; Lappi LR; Rice TK J Med Chem; 1978 Sep; 21(9):941-8. PubMed ID: 102797 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines. Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926 [TBL] [Abstract][Full Text] [Related]
4. Predictive structure-activity relationships in a series of pyranoquinoline derivatives. A new primate model for the identification of antiallergic activity. Gould KJ; Manners CN; Payling DW; Suschitzky JL; Wells E J Med Chem; 1988 Jul; 31(7):1445-53. PubMed ID: 2455052 [TBL] [Abstract][Full Text] [Related]
5. [Effects of MY-5116 on PCA reaction and on the histamine release from peritoneal cells induced by antigen antibody reactions]. Takahashi K; Shono T Nihon Yakurigaku Zasshi; 1986 Jan; 87(1):29-39. PubMed ID: 2420688 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines. Erickson EH; Hainline CF; Lenon LS; Matson CJ; Rice TK; Swingle KE; Van Winkle M J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents]. Yamada N; Takahashi K; Endoh K; Arai Y Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983 [TBL] [Abstract][Full Text] [Related]
8. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat. Riley PA; Mather ME; Keogh RW; Eady RP Int Arch Allergy Appl Immunol; 1987; 82(1):108-10. PubMed ID: 3026967 [TBL] [Abstract][Full Text] [Related]
9. Structure--activity relationships in a series of novel 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylic acid antiallergy agents. Althuis TH; Kadin SB; Czuba LJ; Moore PF; Hess HJ J Med Chem; 1980 Mar; 23(3):262-9. PubMed ID: 6767846 [TBL] [Abstract][Full Text] [Related]
10. Nitrogen bridgehead compounds. 18. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 1. Hermecz I; Breining T; Mészáros Z; Horváth A; Vasvári-Debreczy L; Dessy F; DeVos C; Rodriguez L J Med Chem; 1982 Oct; 25(10):1140-5. PubMed ID: 6183427 [TBL] [Abstract][Full Text] [Related]
11. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acids. 1. Erickson EH; Lappi LR; Rice TK; Swingle KF; Van Winkle M J Med Chem; 1978 Sep; 21(9):984-8. PubMed ID: 722763 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue. Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530 [TBL] [Abstract][Full Text] [Related]
13. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. Wells E; Jackson CG; Harper ST; Mann J; Eady RP J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents. Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of the effects of sodium cromoglycate and nedocromil sodium. I]. Salcedo FA; Olivé Pérez A Rev Alerg Mex (1987); 1988; 35(3):59-64. PubMed ID: 2854297 [No Abstract] [Full Text] [Related]
16. [Chemistry and pharmacology of pyran derivatives. XVII. Synthesis of 2-(dialkylamino)-5-hydroxychromones and their transformation to derivatives of 2H-pyran[4,3,2-de]-1-benzopyran]. Mazzei M; Ermili A; Balbi A; Di Braccio M; Schiantarelli P; Cadel S Farmaco Sci; 1986 Aug; 41(8):611-21. PubMed ID: 3743752 [TBL] [Abstract][Full Text] [Related]
17. Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity. Althuis TH; Moore PF; Hess HJ J Med Chem; 1979 Jan; 22(1):44-8. PubMed ID: 106118 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of allergic reactions by chromoglycate and by a new anti-allergic drug (10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido (3,2-g) quinoline-2,8-dicardoxylic acid). I. Activity in rats. Johnson HG; van Hout CA Int Arch Allergy Appl Immunol; 1976; 50(4):446-53. PubMed ID: 55394 [TBL] [Abstract][Full Text] [Related]
19. Conjugation of disodium 6-chloro-4-oxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxy late with glutathione in the rat. Smith DA; Johnson PM; Wilkinson DJ Xenobiotica; 1985 May; 15(5):437-44. PubMed ID: 4041094 [TBL] [Abstract][Full Text] [Related]
20. MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells. Yamada N; Kadowaki S; Takahashi K; Umezu K Biochem Pharmacol; 1992 Sep; 44(6):1211-3. PubMed ID: 1358073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]